Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b22-00917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Masaki Hirabatake und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kobe City Medical Center General Hospital. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Kobe City Medical Center General Hospital.
- Department of Urology, Kobe City Medical Center General Hospital.
- Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University.
Zitieren
APA
Hirabatake, M., Ikesue, H., Yoshino, S., Morimoto, M., Yamasaki, T., Hashida, T., Kawakita, M., & Muroi, N. (2023). Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00917
Vancouver
Hirabatake M, Ikesue H, Yoshino S, Morimoto M, Yamasaki T, Hashida T, et al. Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00917
BibTeX
@article{Hirabatake2023,
author = {Hirabatake, Masaki and Ikesue, Hiroaki and Yoshino, Shintaro and Morimoto, Mayu and Yamasaki, Toshinari and Hashida, Tohru and Kawakita, Mutsushi and Muroi, Nobuyuki},
title = {Pharmacist–Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b22-00917}
}
EUVIMED